VVOS
Vivos Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.16
−7.27%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.17
From 52W high−95.31%
Volume1.59M
Market cap$3.28M
P/E (TTM)—
P/S (TTM)0.2x
Div yield—
Key dataSep 18, 2026
Open
$0.17
From 52W high
−95.31%
Volume
1.59M
Market cap
$3.28M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.6x
P/E (TTM)
—
RSI (14)
31.7
MomentumView details →
1D Return
−7.27%
YTD Return
−91.95%
SummaryUpdated Jun 1, 2026
Vivos Therapeutics, Inc. (NASDAQ:VVOS) is a medical technology company founded in 2016 and based in Highlands Ranch, Colorado. The company went public in December 2020 and specializes in developing non-invasive treatment alternatives for patients suffering from dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring. Vivos has undergone significant strategic transformation since its founding, evolving from a dental-focused distribution model to a medical sleep center partnership approach, while maintaining its core focus on providing alternatives to traditional CPAP therapy for sleep apnea patients.
Similar companies
Latest newsMore news →
Vivos Therapeutics entered into twelve exchange agreements with Streeterville Capital on August 31, 2026, exchanging $2.86 million of outstanding principal under its secured promissory note for 11.445 million shares of common stock at $0.25 per share.11d agoVivos Therapeutics, Inc. entered into an Exchange Agreement with Streeterville Capital, LLC to exchange securities for $8,225,000 and $3,250,000 in total value.12d agoVivos Therapeutics, Inc. entered into a securities purchase agreement for a PIPE offering of 3,608,496 units at $0.582 per unit, raising approximately $2.1 million, with each unit consisting of one share of Series A Convertible Preferred Stock and a five-year warrant.75d ago